• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Med Res Methodol . Cohort retention in a pandemic response study: lessons from the SARS-CoV2 Immunity & Reinfection Evaluation (SIREN) study

tetano

Editor, Senior Moderator
BMC Med Res Methodol


. 2025 Jan 30;25(1):27.
doi: 10.1186/s12874-025-02469-6. Cohort retention in a pandemic response study: lessons from the SARS-CoV2 Immunity & Reinfection Evaluation (SIREN) study

Anna Howells[SUP] 1 [/SUP], Katie Munro[SUP] 2 [/SUP], Sarah Foulkes[SUP] 2 [/SUP], Atiya Kamal[SUP] 3 [/SUP], Jack Haywood[SUP] 2 [/SUP], Sophie Russell[SUP] 2 [/SUP], Dominic Sparkes[SUP] 2 [/SUP], Erika Aquino[SUP] 4 [/SUP], Jennie Evans[SUP] 4 [/SUP], Dale Weston[SUP] 2 [/SUP], Susan Hopkins[SUP] 2 [/SUP], Jasmin Islam[SUP] 2 [/SUP], Victoria Hall[SUP] 5 [/SUP]



Affiliations
Abstract

Background: SIREN is a healthcare worker cohort study aiming to determine COVID-19 incidence, duration of immunity and vaccine effectiveness across 135 NHS organisations in four UK nations. Conducting an intensive prospective cohort study during a pandemic was challenging. We designed an evolving retention programme, informed by emerging evidence on best practice. This included applying a multifactorial approach, and considering strategies for barrier reduction, community building, follow-up, and tracing. We utilised participant engagement tools underpinned by our Participant Involvement Panel (PIP) and here we evaluate cohort retention over time and identify learnings.
Methods: A mixed method evaluation of cohort retention in 12 and 24-month follow-up (June 2020 - March 2023). We described cohort retention by demographics and site, using odds ratios from logistic regression. Withdrawal reasons during this time were collected by survey. We collected participant feedback via cross-sectional online survey conducted October - November 2022, utilising a behavioural science approach. We conducted two focus groups with research teams in February 2023 and conducted thematic analysis exploring cohort retention challenges and facilitators.
Results: 37,275 (84.7%) participants completed 12-months of follow-up. Of 14,772 participants extending their follow-up to 24 months, 12,635 (85.5%) completed this. Retention increased with age in the 12 (55-64 years vs < 25 years OR = 2.50; 95% CI: 2.19-2.85; p < 0.001) and 24-month (> 65 years vs < 25 years OR = 2.92; 95% CI: 1.78-4.88; p < 0.001) cohorts. Retention was highest in the Asian and Black ethnic groups compared to White in the 12 (OR = 1.38; 95% CI: 1.23-1.56; p < 0.001, and OR = 1.64; 95% CI: 1.30-2.08; p < 0.001) and 24-month (OR = 1.78; 95% CI: 1.42-2.25; p < 0.001, and OR = 2.12; 95% CI: 1.41-3.35; p < 0.001) cohort. Among participants withdrawing, the median time in follow-up at withdrawal was 7 months (IQR: 4-10 months) within the 12-month cohort and 19 months within the 24-month cohort (IQR: 16-22 months). The top three reasons for participant withdrawal were workload, leaving site employment and medical reasons. Themes identified from focus-groups included: the need to monitor and understand participant motivation over time, the necessity of inclusive and comprehensive communication, the importance of acknowledging participant contributions, building collaboration with local research teams, and investing in the research team skillset.
Conclusion: Participant retention in the SIREN study remained high over 24-months of intensive follow-up, demonstrating that large cohort studies are feasible as a pandemic research tool. Our evaluation suggests it is possible to maintain an engaged cohort of healthcare workers (HCWs) during an acute pandemic response phase. The insights gained from this population group are important, as a highly exposed group fulfilling an essential pandemic response and patient care function. The success of the cohort study overall, as well as the specific population group retained, offer useful insight for pandemic preparedness planning and healthcare worker studies.

Keywords: COVID-19; Cohort retention; Coronavirus; Pandemic response; Participant engagement; Participant involvement; SARS-CoV-2; SIREN.

 
Back
Top Bottom